Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 6.96% vs 6.47% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -24.84% vs -6.70% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -11.89% vs 20.64% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -19.57% vs 29.94% in Mar 2025
Compare Profit and Loss Results of TTK Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
857.00
2,699.00
-1,842.00
-68.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
857.00
2,699.00
-1,842.00
-68.25%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
3.00
-3.00
-100.00%
Raw Materials Consumed
403.00
1,068.00
-665.00
-62.27%
Power & Fuel Cost
24.00
42.00
-18.00
-42.86%
Employee Cost
165.00
266.00
-101.00
-37.97%
Operating Expenses
31.00
760.00
-729.00
-95.92%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
145.00
72.00
73.00
101.39%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
110.00
-101.00
-91.82%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
831.00
2,363.00
-1,532.00
-64.83%
Operating Profit (PBDIT) excl Other Income
26.00
335.00
-309.00
-92.24%
Other Income
72.00
85.00
-13.00
-15.29%
Operating Profit (PBDIT)
98.00
420.00
-322.00
-76.67%
Interest
2.00
25.00
-23.00
-92.00%
Profit before Depriciation and Tax
95.00
395.00
-300.00
-75.95%
Depreciation
8.00
64.00
-56.00
-87.50%
Profit Before Taxation & Exceptional Items
86.00
330.00
-244.00
-73.94%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
82.00
330.00
-248.00
-75.15%
Provision for Tax
16.00
85.00
-69.00
-81.18%
Profit After Tax
65.00
245.00
-180.00
-73.47%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
940.00
1,037.00
-97.00
-9.35%
Profit Available for appropriations
1,005.00
1,282.00
-277.00
-21.61%
Appropriations
1,005.00
1,282.00
-277.00
-21.61%
Equity Dividend (%)
100%
85%
15.00
Earnings Per Share
46.48
14.37
32.11
223.45%
Profit And Loss - Net Sales
Net Sales 857.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.96% vs 6.47% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.18 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -24.84% vs -6.70% in Mar 2025
Profit And Loss - Interest
Interest 2.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -11.89% vs 20.64% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 65.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -19.57% vs 29.94% in Mar 2025
